Servo-Med Industries Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 2.00 M
as on 16-11-2024
- Company Age 30 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.64 Cr
as on 16-11-2024
- Satisfied Charges ₹ 9.53 M
as on 16-11-2024
- Revenue 21.53%
(FY 2023)
- Profit -8.94%
(FY 2023)
- Ebitda 19.47%
(FY 2023)
- Net Worth 25.89%
(FY 2023)
- Total Assets 15.92%
(FY 2023)
About Servo-Med Industries
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.64 Cr. The company has closed loans amounting to ₹9.53 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Desai and Ninad Desai serve as directors at the Company.
- CIN/LLPIN
U33110MH1994PTC078715
- Company No.
078715
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Servo-Med Industries Private Limited offer?
Servo-Med Industries Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Catheter, Urological & Obstetrics Instruments, Urinary Catheter.
Who are the key members and board of directors at Servo-Med Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Desai  | Director | 02-Jun-1994 | Current |
| Ninad Desai | Director | 02-Jun-1994 | Current |
Financial Performance of Servo-Med Industries.
Servo-Med Industries Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.53% increase. The company also saw a slight decrease in profitability, with a 8.94% decrease in profit. The company's net worth Soared by an impressive increase of 25.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Servo-Med Industries?
In 2023, Servo-Med Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Oct 2021 | ₹1.64 Cr | Open |
Bank Of Baroda Creation Date: 17 Aug 2006 | ₹9.00 M | Satisfied |
Bank Of Baroda Creation Date: 12 Sep 2000 | ₹0.53 M | Satisfied |
How Many Employees Work at Servo-Med Industries?
Servo-Med Industries has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Servo-Med Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Servo-Med Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
